Theme 2 - the role of antibodies in Covid infection
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-516
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Emma WallResearch Location
United KingdomLead Research Institution
Francis Crick InstituteResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The Legacy Study will utilise a unique bank of over 400,000 coronavirus samples at the Crick, gathered as part of the institute's testing partnership with many north London healthcare facilities, including UCLH. Scientists and clinicians will aim to understand the coronavirus and how it behaves in individuals - how the virus is transmitted between people, how later stages of the disease develop and how the body's immune system attempts to control the virus. ... "With informed consent, samples will be matched with individuals to establish how factors like age, sex, ethnicity, and past and current medical histories, impact the risk of infection. Participants will also be invited to give regular swab and blood samples over two years, to better understand how emerging variants and vaccination affect risk of infection and how the body responds." - from Crick news article August 2021.